Addex further improves liquidityFollowing a private placement worth CHF3m in February, Swiss allosteric modulator specialist Addex Therapeutics has increased its capital to finance clinical studies of dipraglurant in Parkinsons and … more ➔
AMO Pharma receives FDA Fast Track Status London-based orphan drug developer AMO Pharmas drug AMO-02 has been granted FDA fast track status as treatment for congenital myotonic dystrophy, a sub-indication muscular dystrophy. more ➔
Biocorp partners with VirbacFrench drug delivery specialist Biocorp S.A. (Issoire) has signed an industrialisation contract with Virbac, one of the top-ten vet-med makers. more ➔
Janssen speeds up guselkumab approval proc...Janssen speeds up US approval of psoriasis antibody guselkumab and targets further indications. more ➔
Abzenas partner True North Therapeutics...British Abzena plc has announced that True North Therapeutics (TNT) will be taken over by Bioverativ Inc. Bioverativ will further develop TNT’s complement factor C1-blocking antibody TNT009, developed … more ➔
RA: Sanofi/Regeneron IL-6R blocker FDA-app...Following the EMAs recommendation for EU approval of sarilumab as second-line treatment for rheumatoid arthritis, French drug giant Sanofi and partner Regeneron have also been given the green light … more ➔
Safety event delays US market approval of...Top-Line Phase 3 data of Amgens/UCBs osteoporosis antibody romosozumab in postmenopausal women suggest efficacy but uncover a new safety signal. more ➔
Vesalius Biocapital fund raises €65mLuxembourg-based venture capital specialist Vesalius Biocapital has closed the first round of Biocapital III fund that aims to invest into later-stage European life sciences companies. more ➔
Merck presents new CRISPR genome editing m...German Merck KGaA has developed a new genome editing tool dubbed proxy-CRISPR providing access to previously inaccessible microenviroments of the genome by modification of chromatin modification … more ➔
Astellas completes Ogeda takeoverAstellas Pharma Inc. has completed the acquisition of Ogeda SA (previously Euroscreen SA, Gosselies, Belgium). more ➔
